1 Sept London South East (Link) “Investors have reacted logically to the prospect of even more and accelerated generic competition eroding up to 80% of Indivior’s already waning US market share for the drug ‘within months’,” said Accendo Markets analyst Mike Van Dulken 31 Aug Fox Business (Link) This is some welcome good news from Asia following…
September has only just begun, however already, alongside the acceleration of the expected customary September volume increase, there is a plentiful helping of stocks from one of retail investors’ favourite sector, the Housebuilders. As has almost become customary, the sector wheels some of its largest names out to report numbers almost as soon as the…
It makes sense for investors’ first reaction to a catastrophe such as Hurricane Harvey to be the identification of companies and share prices which may be negatively impacted. The reasons are three-fold. Firstly, am I in these names, do I need to protect profits and/or can I avoid worsening of losses? Secondly, let me keep…
It’s been quite the fall from grace for Indivior shares this morning – down up to 40% to levels traded last July – after a US court ruled that competitor drugs for its Suboxone Film for heroin addiction treatment don’t infringe on its patents. Generic competition has already trimmed Indivior’s US market share for the…
During the penultimate week of August, you could be forgiven for believing that the market would be quiet. However, after the past five sessions, that couldn’t be further from the truth. Reaching the conclusion of the summer months, fund managers, traders and investors alike typically end their summer sabbatical with a return to the markets….
Whilst it’s perfectly acceptable to get swept up in the storm of headlines that follow profits warnings, it’s much harder to assess the overall impact of these sensational events. So while many traders were focused on the share price declines of Provident Financial, WPP and Dixons Carphone, they may have missed the Mining sector charging to…